oral lichen planus. Other lichen planus
Conditions
Interventions
Intervention 1: Intervention group: In this group, patients will receive topical corticosteroid in addition to lycopene, patient will use the drug 4 times a day for 2 weeks (An hour befor each meal
Treatment - Drugs
Placebo
Intervention group: In this group, patients will receive topical corticosteroid in addition to lycopene, patient will use the drug 4 times a day for 2 weeks (An hour befor each meal and 20 minutes
control group:In this group, patient will receive just topical corticosteroide and patient will to use the drug 4 times a day for 2 weeks (An hour befor each meal and 20 minutes befor sleep), and avoi
Sponsors
Vice chancellor for research,Zahedan University of Medical Sciences
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: Inclusion criteria:Diagnostic criteria is clinical and histopathological view of the lesions. Exclusion criteria: patients with systemic disease, skin lichen planus, drug user, pregnant wemen, smokers, patients with dysplastic lesions and lesions close to restorations and also patients receiving treatment for oral lesions was than a month ago.
Exclusion criteria
Exclusion criteria:
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Reduction in size of the lesion. Timepoint: Before starting treatment, every week for 12 weeks after starting treatment. Method of measurement: In each follow up session size of the lesion will be measured by caliper. | — |
Secondary
| Measure | Time frame |
|---|---|
| Reduced pain of the lesion. Timepoint: Before starting treatment, every week for 12 weeks after starting treatment. Method of measurement: Use of Visual Analoge Scale (VAS) from 0- 10, 0: no pain sensation and 10: severe pain sensation. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactDr. Fateme Arbabi Kalati
Zahedan University of Medical Sciences
Outcome results
None listed